Correlation Between Invesco SP and VanEck Pharmaceutical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Invesco SP and VanEck Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Invesco SP and VanEck Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Invesco SP 500 and VanEck Pharmaceutical ETF, you can compare the effects of market volatilities on Invesco SP and VanEck Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Invesco SP with a short position of VanEck Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Invesco SP and VanEck Pharmaceutical.

Diversification Opportunities for Invesco SP and VanEck Pharmaceutical

-0.8
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Invesco and VanEck is -0.8. Overlapping area represents the amount of risk that can be diversified away by holding Invesco SP 500 and VanEck Pharmaceutical ETF in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on VanEck Pharmaceutical ETF and Invesco SP is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Invesco SP 500 are associated (or correlated) with VanEck Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of VanEck Pharmaceutical ETF has no effect on the direction of Invesco SP i.e., Invesco SP and VanEck Pharmaceutical go up and down completely randomly.

Pair Corralation between Invesco SP and VanEck Pharmaceutical

Given the investment horizon of 90 days Invesco SP 500 is expected to generate 0.97 times more return on investment than VanEck Pharmaceutical. However, Invesco SP 500 is 1.03 times less risky than VanEck Pharmaceutical. It trades about 0.2 of its potential returns per unit of risk. VanEck Pharmaceutical ETF is currently generating about -0.25 per unit of risk. If you would invest  5,237  in Invesco SP 500 on August 27, 2024 and sell it today you would earn a total of  189.00  from holding Invesco SP 500 or generate 3.61% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Invesco SP 500  vs.  VanEck Pharmaceutical ETF

 Performance 
       Timeline  
Invesco SP 500 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Invesco SP 500 are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of rather abnormal basic indicators, Invesco SP may actually be approaching a critical reversion point that can send shares even higher in December 2024.
VanEck Pharmaceutical ETF 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days VanEck Pharmaceutical ETF has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest inconsistent performance, the Etf's basic indicators remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the Etf traders.

Invesco SP and VanEck Pharmaceutical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Invesco SP and VanEck Pharmaceutical

The main advantage of trading using opposite Invesco SP and VanEck Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Invesco SP position performs unexpectedly, VanEck Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VanEck Pharmaceutical will offset losses from the drop in VanEck Pharmaceutical's long position.
The idea behind Invesco SP 500 and VanEck Pharmaceutical ETF pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Other Complementary Tools

Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon